Früher|Nächster

Syndrome differentiation and treatment of carcinoma of prostate based on the pathogenesis theory of cancer toxin

  • role： First author第一作者
  • Affiliation：

    The First Clinical School of Nanjing University of Chinese Medicine, Nanjing 210023, China

  • Introduction：李晨，女，在读硕士生
LI Chen1,  
  • Affiliation：

    The First Clinical School of Nanjing University of Chinese Medicine, Nanjing 210023, China

YAO Yuan1,  
  • Affiliation：

    The First Clinical School of Nanjing University of Chinese Medicine, Nanjing 210023, China

    Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing 210023, China

LI Liu12,  
  • Affiliation：

    Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China

WANG Junyi3,  
  • role： Corresponding author通信作者
  • Affiliation：

    The First Clinical School of Nanjing University of Chinese Medicine, Nanjing 210023, China

    Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing 210023, China

  • Email：hbcheng@njucm.edu.cn
  • Introduction：Prof. CHENG Haibo, Ph.D., Chief Physician, Doctoral Supervisor. Nanjing University of Chinese Medicine, No.138, Xianlin Dadao, Qixia District, Nanjing 210023.E-mail: hbcheng@njucm.edu.cn
CHENG Haibo12*

Resümee

Our team created the pathogenesis theory of cancer toxin in traditional Chinese medicine on the basis of inheriting the academic thought of "cancer toxins" of ZHOU Zhongying, a Chinese medical master.The pathogenesis theory of cancer toxin suggests that cancer toxins is the key factor leading to the occurrence and development of malignant tumors, the basic pathogenesis of malignant tumor is accumulation of evil and toxins, deficiency of vital qi. This paper proposes that the main pathological factors of carcinoma of prostate are deficiency, dampness, heat, stasis and toxins. The core pathogenesis was spleen and kidney deficiency, dampness-heat stasis toxin accumulation in essence chamber. The disease is located in the essence chamber, closely related to kidney and bladder, and involves liver and spleen. Clinical treatment is based on anti-cancer and detoxification, strengthening vital qi to eliminate pathogenic factor as the basic treatment principles, treatment with anti-cancer detoxification as the core, tonifying the spleen and kidney as the fundamental, clearing heat and removing dampness, removing blood stasis and dispersing is key, accompanied by dispersing liver and regulating qi, the whole syndrome differentiation, to maintain a stable period of time. Strengthening vital qi does not leave evil, eliminating evil does not harm vital qi. Guided by the pathogenesis theory of cancer toxin, this paper expounds the treatment of carcinoma of prostate based on syndrome differentiation and highlights the key role of the pathogenesis theory of cancer toxin in the treatment of this disease, providing reference for the differentiation and treatment of carcinoma of prostate.

Schlüsselwort

cancer toxin;pathogenesis theory;carcinoma of prostate;treatment based on syndrome differentiation;therapeutic principles and methods

References

  1. [1].
    张成铭，徐荷芳．恶性肿瘤病机初探[J].辽宁中医杂志，1988，15(12):9-11.
  2. [2].
    程海波，吴勉华，周红光．周仲瑛从癌毒辨治恶性肿瘤的经验[J].北京中医药，2009，28(11):844-846.
  3. [3].
    程海波，吴勉华．周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志，2010，25(6):866-869.
  4. [4].
    程海波，李柳，孙东东，等．癌毒病机理论探讨[J].中医杂志，2014，55(20):1711-1715.
  5. [5].
    尹周一，王梦圆，游伟程，等.2022美国癌症统计报告解读及中美癌症流行情况对比[J].肿瘤综合治疗电子杂志，2022，8(2):54-63.
  6. [6].
    CHEN WQ, ZHENG RS, BAADE PD, et al. Cancer statistics in China，2015[J].CA Cancer J Clin，2016，66(2):115-132.
  7. [7].
    SUNG H, FERLAY J, SIEGEL R, et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin，2021，71(3):209-249.
  8. [8].
    中华医学会男科学分会，前列腺癌中西医结合诊疗与健康管理中国专家共识编写组．前列腺癌中西医结合诊疗与健康管理中国专家共识[J].中华男科学杂志，2022，28(10):941-953.
  9. [9].
    牛潇菲，张畅，李小江．基于CiteSpace的中医药治疗前列腺癌可视化分析[J].中医药导报，2021，27(8):160-164.
  10. [10].
    周仲瑛，程海波，周学平，等．中医药辨治肿瘤若干理念问题的探讨[J]. 南京中医药大学学报，2014，30(2):101-104.
  11. [11].
    程海波，王俊壹，李柳．癌毒病机分类及其在肿瘤临床治疗中的应用[J].中医杂志，2019，60(2):119-122.
  12. [12].
    李柳，程海波．中医肿瘤癌毒证候特征探讨[J].中医杂志，2022，63 (2):106-110.
  13. [13].
    程海波，李柳，沈卫星，等．癌毒病机辨治体系的构建[J].南京中医药大学学报，2022，38(7):559-564.
  14. [14].
    程海波，李柳，周学平，等. 中医肿瘤癌毒病机辨证体系的创建[J].中医杂志，2020，61 (20):1767-1770.
  15. [15].
    巢元方．诸病源候论[M].黄作阵，校注．沈阳：辽宁科学技术出版社，1997.
  16. [16].
    魏小曼，李柳，王俊壹，等．癌毒病机理论辨治胰腺癌探讨[J].中华中医药杂志，2022，37(4):2062-2065.
  17. [17].
    SARWAR S, AMED T, QAZI NG. Prospects of wedelolactone as a chemotherapeutic agent in gynecological cancers; clue from its in vitro and in silico investigation[J].Curr Comput Aided Drug Des，2020，16(4):365-375.
  18. [18].
    WANG Q, ZI CT, WANG J, et al. Dendrobium officinale orchid extract prevents ovariectomy-induced osteoporosis in vivo and inhibits RANKL-induced osteoclast differentiation in vitro[J].Front Pharmacol，2018，8:966.
  19. [19].
    尤在泾．柳选四家医案[M].盛燕江，校注．北京：中国中医药出版社，1997: 116.
  20. [20].
    方妍，李柳，程海波．基于湿毒病机探讨祛湿解毒法在恶性肿瘤防治中的应用[J].江苏中医药，2023，55(8):60-63.
  21. [21].
    李中梓．医宗必读[M].王卫，点校．天津：天津科学技术出版社，1999：256.
  22. [22].
    田虎，田思胜．恶性肿瘤血液高凝状态的中医药治疗[J].中医杂志，2019，60(7):572-575.
  23. [23].
    王肯堂．灵兰要览[M].戴祖铭，点校．南京：江苏科学技术出版社，1987：28.
  24. [24].
    贺习婷，杜井富，刘咏菲，等．常见恶性肿瘤的中医治疗原则浅析[J].中西医结合心血管病电子杂志，2020，8(4):39.

Lesen Sie die ganze Passage

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website